SoftMedx Healthcare Limited announced the completion of its specific-mandate share issuance on 1 April 2026, following the fulfilment of all conditions precedent. A total of 16.30 million new shares (the “Scheme Shares”) were allotted, expanding the company’s issued share capital from 2.13 billion to 2.14 billion shares.

Post-issue shareholding structure: • Multi Omniverse Group Limited remains the controlling shareholder with 1.59 billion shares, though its stake diluted slightly from 74.90% to 74.40%. • The newly issued 16.30 million shares are held by a designated trustee, representing 0.76% of the enlarged capital. • Other public shareholders continue to hold 533.04 million shares, now accounting for 24.90% (previously 25.10%).

As a result, SoftMedx’s total public float (trustee plus other public shareholders) stands at 25.66%, compared with 25.10% before the transaction.